Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Scribner (NPI 1144830803)

Field	Value
Entity Type	Individual
Organization	Robert Scribner
Address	27209 Lahser Rd Ste 120
City	Southfield
State	MI
ZIP	48034
Taxonomy	Gerontology Nurse Practitioner
NPI Enumerated	August 6, 2020

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

ROBERT SCRIBNER is effectively a Medicare-only biller: lifetime Medicare revenue is $1.5M and there is no Medicaid billing on file, indicating a single-payer footprint in these datasets rather than a dual Medicare/Medicaid practice mix. Analysts should treat Medicaid-related service-lines or state-level Medicaid competitive conclusions as not applicable for this provider due to absent Medicaid claims.

Revenue concentration is high among a few drug administration codes: the precomputed top 3 Medicare codes by revenue account for 57.0% of the provider's total Medicare revenue, signaling that a majority of Medicare receipts are driven by a small set of biologic/injectable drug codes rather than a broad portfolio of evaluation-and-management services. This suggests operational focus on infusion or injection-based therapy delivery.

The single largest revenue driver is J9332 (efgartigimod alfa-fcab), which accounts for $444.9K and 30.2% of Medicare revenue. Combined with other high-volume biologic injections such as J3380 and J3245, the code mix indicates the practice primarily administers specialty infusions and high-cost injectable biologic therapies to Medicare beneficiaries rather than routine primary-care procedures.

Competitive standing across national peers is mixed but generally modest: for its top code J9332 the provider ranks #5 of 5 providers nationally (described in the source as 0th percentile and “typical, unremarkable volume”), and for J3380 the provider ranks #163 of 620 (73th percentile). Those rank positions imply the provider is not a dominant national leader for J9332 and is a mid-to-upper-tier participant for some other biologic infusions, rather than a market leader across the board.

Several high-revenue codes are at low national percentiles, implying concentrated but not exceptional volume by peer standards: J3245 (rank #216 of 225, 3th percentile) and J1306 (rank #442 of 462, 2th percentile) both appear near the bottom of their national peer lists despite contributing materially to this provider's revenue, so the provider’s overall Medicare revenue is driven by codes where their national market position is modest-to-minor.

The practice shows operational throughput for infusion administration in addition to drug billing: administration codes such as 96365, 96401, and 96413 appear on the top code list, accounting for measurable but smaller shares of revenue (for example 96365 is $11.2K and 0.8% of Medicare revenue). This combination of drug HCPCS and infusion administration CPTs supports a service-line that delivers and bills both the biologic drug and its onsite administration.

Tenure in Medicare billing is recent-to-midterm: the NPI was enumerated on 2020-08-06 (~6 years ago), indicating the provider has multiple years of claims history but is not a long-established Medicare submitter compared with providers enumerated decades earlier. That tenure aligns with the observed concentration in specialty biologics, which often correspond to more recent therapeutic lines.

Payer and service-line risk concentration should be noted for contracting and network strategy: with $1.5M of revenue entirely from Medicare and 57.0% of that tied to the top three injectable biologic codes, the provider represents a specialized revenue stream that would be sensitive to changes in Medicare drug coverage, reimbursement for specific HCPCS codes, or shifts in referral patterns for infusion services. Payers evaluating network inclusion or capitation exposure should account for this narrow revenue profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9332	Injection, efgartigimod alfa-fcab, 2mg	17,800	$30	$444.9K
J3380	Injection, vedolizumab, intravenous, 1 mg	12,900	$20	$219.3K
J3245	Injection, tildrakizumab, 1 mg	1,600	$110	$174.4K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	3,030	$30	$102.8K
J2182	Injection, mepolizumab, 1 mg	3,700	$20	$85.1K
J0897	Injection, denosumab, 1 mg	4,560	$20	$82.1K
J2356	Injection, tezepelumab-ekko, 1 mg	4,410	$10	$61.7K
J0517	Injection, benralizumab, 1 mg	450	$130	$59.4K
J3262	Injection, tocilizumab, 1 mg	11,730	$10	$58.7K
J2357	Injection, omalizumab, 5 mg	1,790	$30	$53.5K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Robert Scribner — 0 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9332	1	10	17,800	$20	$443.5K
J3245	5	10	3,900	$110	$391.8K
J0129	18	20	7,700	$30	$285.5K
J2357	11	10	6,600	$30	$222.2K
J3380	4	10	10,500	$20	$216.4K
J3262	9	10	26,240	$1	$191.1K
J0517	2	10	1,410	$130	$186.5K
J2182	1	10	3,700	$20	$85.5K
J1745	12	20	2,150	$30	$77.3K
J0897	44	170	2,460	$20	$69.1K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Scribner, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Metro Infectious Disease Consultants, LLC	IL	Infectious Disease Physician	$0	$44.3M
Natalia Surowaniec	IL	Family Nurse Practitioner	$2.1M	$0
Martha Pawlukowsky	IL	Family Nurse Practitioner	$2M	$1.3K
Margaret Denham	IN	Nurse Practitioner	$1.7M	$0
Marie Rodriguez	IL	Gerontology Nurse Practitioner	$1.7M	$0
Walter Marbach	IL	Rheumatology Physician	$1.6M	$53.2K
Brooke Raney	IA	Family Nurse Practitioner	$1.6M	$0
Kristin Elatkin	IL	Family Nurse Practitioner	$1.6M	$5K
Vishnu Chundi	IL	Infectious Disease Physician	$978.9K	$354.9K
Kimberly Balshi	FL	Nurse Practitioner	$1.3M	$0

Nearby Providers

Other providers in the same ZIP code as Robert Scribner, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Pro Care Unlimited, LLC	MI	Home Health Agency	$0	$216M
Coordinated Community Living	MI	Home Health Agency	$0	$85.8M
Vhs Physicians Of Michigan	MI	Internal Medicine Physician	$0	$73.9M
Angels' Place	MI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$18.1M
North West Labs, Inc.	MI	Clinical Medical Laboratory	$1.4M	$10.9M
Great Lakes Surgical Center LLC	MI	Ambulatory Surgical Clinic/Center	$82.6K	$4M
City Of Southfield	MI	Ambulance	$845.3K	$1.8M
Biogenetics Laboratories, Inc.	MI	Clinical Medical Laboratory	$648.4K	$1.9M
Michael Ober	MI	Ophthalmology Physician	$1.8M	$0
Darrin Levin	MI	Ophthalmology Physician	$1.5M	$0

Robert Scribner — Billing Profile & Reimbursement Data

Sign up for Robert Scribner — Billing Profile & Reimbursement Data policy alerts

Robert Scribner — Billing Profile & Reimbursement Data

Sign up for Robert Scribner — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References